Skip to content
Research use onlyComplimentary shipping on orders over $200 U.S. fulfillment
Metabolic & Endocrine

P1-2 TZ

$200Per vial

A dual-receptor peptide studied for activity across GLP-1 and GIP pathways, used in research on incretin-mediated metabolic and endocrine signaling. Its dual-agonist mechanism allows researchers to investigate how combined incretin receptor activation influences glucose homeostasis and metabolic coordination.

Vial size2 options

Backordered · Ships as soon as restocked

1
Complimentary shipping over $200 U.S.-based fulfillment
Ships as soon as this size is restocked
Batch record published · 99.74%

Lot P1P-TZ30-001 · Janoshik

For laboratory research only. Not for human or veterinary use.

About P1-2 TZ

P1-2 TZ Overview

P1-2 TZ is a dual-receptor peptide studied for activity across GIP and GLP-1 pathways. In research settings, it is used to examine how these two receptor systems work together and how combined receptor activity influences broader metabolic and endocrine signaling. P1-2 TZ has been described in the literature as an acylated peptide engineered to activate both the GIP and GLP-1 receptors.

Mechanism of Action & Applications

P1-2 TZ is studied as a dual agonist at the GIP and GLP-1 receptors. This receptor profile allows researchers to examine how simultaneous activation of incretin-related pathways affects intracellular signaling, hormone pathway coordination, and broader metabolic system responses. Published mechanistic work also describes P1-2 TZ as having stronger relative activity at the GIP receptor and biased signaling behavior at the GLP-1 receptor, which makes it a useful compound for studying receptor-selective signaling and dual-incretin pathway biology. It is commonly used in research involving incretin receptor biology, metabolic signaling, endocrine regulation, and multi-pathway peptide signaling.

Research History

P1-2 TZ builds on earlier incretin research that first focused on GLP-1 receptor agonists and later expanded into compounds designed to engage both GIP and GLP-1 receptors. This progression led to dual-agonist peptides like P1-2 TZ, which are studied for more integrated pathway research involving incretin signaling and metabolic system coordination.

Chemical Information

CAS Number
2023788-19-2
Molecular Formula
C225H348N48O68
Molecular Weight
4,813.45 g/mol
PubChem ID
166567236

Researcher Reviews